Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

Rheumatoid arthritis

DMARDs do not increase post-surgical infection risk

Rates of post-surgical infections did not increase for patients taking disease-modifying anti-rheumatic drugs and biologics, researchers discover.

X-ray of arthritic hands

Source: Science Photo Library

To find whether disease-modifying anti-rheumatic drugs are associated with post-operative infections, the researchers analysed surgery data from more than 5,500 patients with rheumatoid arthritis

Disease-modifying anti-rheumatic drugs (DMARDs) and biologics suppress the immune system, so patients with rheumatoid arthritis (RA) sometimes stop taking them before surgery, which could increase their risk of a disease flare-up.

To find out whether DMARDs are associated with post-operative infections, researchers analysed data on 9,362 surgeries for 5,544 RA patients treated with methotrexate, hydroxychloroquine or leflunomide alone, or methotrexate plus a tumour necrosis factor α-inhibitor.

The team found that the rate of post-operative infections or wound infections was no greater in patients who continued therapy compared with those who stopped treatment prior to surgery.

The researchers, who reported their findings at the ACR/ARHP annual meeting in Washington on 14 November 2016[1], say the results suggest disease-modifying treatments can be continued during the perioperative period, which might reduce the need for rescue medication, such as steroids, owing to disease flare-ups.

Citation: Clinical Pharmacist DOI: 10.1211/CP.2016.20201990

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Drugs of Abuse

    Drugs of Abuse

    A concise, easy-to-read guide for healthcare professionals who encounter drug abuse.

    £38.00Buy now
  • Pharmaceutical Toxicology

    Pharmaceutical Toxicology

    Explains the methodology and requirements of pre-clinical safety assessments of new medicines. Includes registration requirements and pharmacovigilance.

    £40.00Buy now
  • Drugs and the Liver

    Drugs and the Liver

    Drugs and the Liver assists practitioners in making pragmatic choices for their patients. It enables you to assess liver function and covers the principles of drug use in liver disease.

    £38.00Buy now
  • Clarke's Analysis of Drugs and Poisons

    Clarke's Analysis of Drugs and Poisons

    Clarke's Analysis of Drugs and Poisons is the definitive reference source of analytical data for drugs and poisons.

    £535.00Buy now
  • International Research in Healthcare

    International Research in Healthcare

    Guidance for students or researchers undertaking a multi-centre research project in health services, medicines use and professional practice.

    £38.00Buy now
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • X-ray of arthritic hands

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.